✦ LIBER ✦

Inhibition of proteasome function induced apoptosis in gastric cancer

✍ Scribed by Xiao Ming Fan; Benjamin Chun Yu Wong; Wei Ping Wang; Xin Min Zhou; Chi Hin Cho; Siu Tsan Yuen; Suet Yi Leung; Marie Chia Mi Lin; Hsiang Fu Kung; Shiu Kum Lam

Publisher: John Wiley and Sons
Year: 2001
Tongue: French
Weight: 348 KB
Volume: 93
Category: Article
ISSN: 0020-7136
DOI: 10.1002/ijc.1373

No coin nor oath required. For personal study only.

✦ Synopsis

The ubiquitin-proteasome pathway plays a critical role in the degradation of cellular proteins and cell cycle control. Dysregulating the degradation of such proteins should have profound effects on tumor growth and causes cells to undergo apoptosis. The aims of this study are to evaluate the ubiquitin-proteasome pathway in gastric cancer and the potential role of pharmacological inhibition of proteasome on induction of apoptosis in gastric cancer cells. Gastric cancer cell lines AGS (p53 wild-type) and MKN-28 (p53 mutant) were treated with proteasome inhibitor MG132. The results showed that MG132 inhibited cell proliferation in AGS and MKN-28 cells in a time- and dose-dependent manner. The inhibition of cell proliferation was caused by apoptosis which was also time- and dose-dependent. AGS cells were more responsive to MG132 than MKN-28 cells. Induction of apoptosis was preceded by the activation of caspase-3, as measured by a colorimetric caspase-3 cellular activity and Western blotting of the cleavage of caspase-3 and its substrate PARP. Activation of caspase-7 was also exhibited. In addition, z-VAD-fmk, a broad spectrum caspase inhibitor, reversed apoptosis induced by MG132 in AGS and MKN28 cells. Although z-DEVD-fmk, a specific caspase-3 inhibitor, suppressed MG132-induced apoptosis in MKN28 cells, it only partially rescued the apoptotic effect in AGS cells. Caspase-3 activation was the result of release of cytochrome c from mitochondria into the cytosol, as a consequence of upregulation of bax. There were overexpressions of all the proteasome-related proteins p53, p21(waf1) and p27(kip1) at 4 hr after proteasome inhibition which was identified by the accumulation of ubiquitin-tagged proteins. This was accompanied by accumulation of cells at G(1) phase. Our present study suggests that inhibition of proteasome function in gastric cancer cells induces apoptosis and proteasomal inhibitors have potential use as novel anticancer drugs in gastric cancer.

📜 SIMILAR VOLUMES

26S proteasome inhibition induces apopto

26S proteasome inhibition induces apoptosis and limits growth of human pancreatic cancer

✍ Shimul A. Shah; Michael W. Potter; Theodore P. McDade; Rocco Ricciardi; Richard 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 335 KB 👁 1 views

## Abstract The 26S proteasome degrades proteins that regulate transcription factor activation, cell cycle progression, and apoptosis. In cancer, this may allow for uncontrolled cell division, promoting tumor growth, and spread. We examined whether selective inhibition of the 26S proteasome with PS

Maspin augments proteasome inhibitor-ind

Maspin augments proteasome inhibitor-induced apoptosis in prostate cancer cells

✍ Xiaohua Li; Di Chen; Shuping Yin; Yonghong Meng; Huanjie Yang; Kristin R. Landis 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 338 KB

## Abstract Proteasome inhibitors are known to induce apoptosis in a variety of cancer cells. On the other hand, maspin, a non‐inhibitory serine protease inhibitor, is shown to sensitize cancer cells to therapeutic agents that induce apoptosis. We examined the consequence of maspin expression in pr

Proteasome inhibition with bortezomib su

Proteasome inhibition with bortezomib suppresses growth and induces apoptosis in osteosarcoma

✍ Yuriy Shapovalov; David Benavidez; Daniel Zuch; Roman A. Eliseev 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 465 KB

## Abstract Osteosarcomas are primary bone tumors of osteoblastic origin that mostly affect adolescent patients. These tumors are highly aggressive and metastatic. Previous reports indicate that gain of function of a key osteoblastic differentiation factor, Runx2, leads to growth inhibition in oste

Pristimerin induces apoptosis by targeti

Pristimerin induces apoptosis by targeting the proteasome in prostate cancer cells

✍ Huanjie Yang; Kristin R. Landis-Piwowar; Dayan Lu; Ping Yuan; Lihua Li; G. Prem- 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 372 KB 👁 1 views

## Abstract Pristimerin is a natural product derived from the __Celastraceae__ and __Hippocrateaceae__ families that were used as folk medicines for antiinflammation in ancient times. Although it has been shown that pristimerin induces apoptosis in breast cancer cells, the involved mechanism of act

Overexpression of gastrokine 1 in gastri

Overexpression of gastrokine 1 in gastric cancer cells induces Fas-mediated apoptosis

✍ Emilia Rippa; Giovanna La Monica; Rosa Allocca; Maria Fiammetta Romano; Maurizio 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 541 KB

## Abstract Gastrokine 1 (GKN1) is involved in the replenishment of the surface lumen epithelial cell layer, in maintaining the mucosal integrity, and could play a role in cell proliferation and differentiation. In fact, after injury of the gastric mucosa, restoration may occur very rapidly in the

Fem1b, a proapoptotic protein, mediates

Fem1b, a proapoptotic protein, mediates proteasome inhibitor-induced apoptosis of human colon cancer cells

✍ M. Cecilia Subauste; Owen J. Sansom; Nehal Porecha; Natacha Raich; Liqin Du; Jos 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 296 KB

## Abstract In the treatment of colon cancer, the development of resistance to apoptosis is a major factor in resistance to therapy. New molecular approaches to overcome apoptosis resistance, such as selectively upregulating proapoptotic proteins, are needed in colon cancer therapy. In a mouse mode